R Michael Carruthers
CIK 1644467 · Chief Financial Officer · last filed 2026-06-08
R Michael Carruthers is a Chief Financial Officer who has filed 27 SEC Form 4 insider transactions across 5 companies since 2015. The most recent filing, for OKUR, was dated Jun 8, 2026. Across all open-market trades the lifetime net is −$5.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.02M
5
27
-$5.04M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OKUR | Director | 4,939 | $4.20 | $20.7K | $0 | 3 | 2026-06-08 |
| EWTX | Chief Financial Officer | 86,162 | $34.83 | $3.00M | -$5.09M | 14 | 2025-08-14 |
| Elevation Oncology, Inc. (ELEV) Delisted | Director | — | $0.36 | — | $0 | 5 | 2025-07-24 |
| Fresh Tracks Therapeutics, Inc. (BBI) Delisted | Chief Financial Officer | — | $2.35 | — | $0 | 1 | 2020-03-18 |
| ALPINE IMMUNE SCIENCES, INC. (NVLS) Delisted | Interim President / CFO | 24,000 | — | — | $50.3K | 4 | 2017-01-23 |
Recent Filings
27 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-08 | OKUR | Grant (A) | — | $0 | EDGAR |
| 2025-08-14 | EWTX | Mixed | +4,353 | -$19.1K | EDGAR |
| 2025-07-24 | Elevation Oncology, Inc. (ELEV) Delisted | Disp (D) | — | $0 | EDGAR |
| 2025-06-09 | Elevation Oncology, Inc. (ELEV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-05-30 | OKUR | Grant (A) | — | $0 | EDGAR |
| 2025-05-07 | EWTX | Mixed | +3,895 | -$21.6K | EDGAR |
| 2024-10-16 | EWTX | Exer (M) | +70,000 | $49.7K | EDGAR |
| 2024-10-08 | OKUR | Grant (A) | +4,939 | $0 | EDGAR |
| 2024-09-24 | EWTX | Mixed | −29,024 | -$3.39M | EDGAR |
| 2024-08-14 | EWTX | Grant (A) | — | $0 | EDGAR |